Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Invitrogen™ Complement Factor I Monoclonal Antibody (OX-21), FITC

Mouse Monoclonal Antibody

Supplier:  Invitrogen™ MA517734

Catalog No. PIMA517734


Only null left
Add to Cart

Description

Description

MA5-17734 targets Factor I in ELISA applications and shows reactivity with Human samples. The MA5-17734 immunogen is human complement Factor I.

Factor I, a serine protease, is a regulatory component of both the alternative and the classical complement pathway. Factor I is synthesized as a single chain precursor of 88 kDa, processed to yield the active form, composed of two disulfide-linked chains, the a-chain (50 kDa) and the b-chain (38 kDa). Plasma concentration is 35 μg/mL.
TRUSTED_SUSTAINABILITY
Specifications

Specifications

Complement Factor I
Monoclonal
0.1 mg/mL
PBS with 4-5mg/mL BSA and 0.02% sodium azide
P05156
CFI
Human complement Factor I.
100 μg
Primary
Human
Antibody
IgG1
ELISA
OX-21
FITC
CFI
AHUS3; ARMD13; C3B/C4B inactivator; C3BINA; C3b-INA; C3b-inactivator; Cfi; complement component factor i; complement component I; complement control protein factor I; complement factor I; Complement factor I heavy chain; Complement factor I light chain; factor i; FI; IF; KAF; Konglutinogen-activating factor; light chain of factor I
Mouse
Protein G
RUO
3426
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. Store in the dark.
Liquid
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.